share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:擬議出售證券
美股sec公告 ·  04/03 23:12
牛牛AI助理已提取核心訊息
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 65,000 Class A shares on 04/03/2024, with an aggregate market value of $574,600. The shares to be sold were acquired through various means, including founders shares received on 09/01/2016, restricted stock vesting on 05/15/2023, and stock option exercises on 06/07/2023 and 07/12/2023. The securities were originally acquired as compensation or through cash payments. This planned sale follows a series of transactions over the past three months, where a total of 230,444 shares were sold for gross proceeds of $2,351,497.24. The notice of the upcoming sale was given in accordance with a plan adopted on 12/27/2023.
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 65,000 Class A shares on 04/03/2024, with an aggregate market value of $574,600. The shares to be sold were acquired through various means, including founders shares received on 09/01/2016, restricted stock vesting on 05/15/2023, and stock option exercises on 06/07/2023 and 07/12/2023. The securities were originally acquired as compensation or through cash payments. This planned sale follows a series of transactions over the past three months, where a total of 230,444 shares were sold for gross proceeds of $2,351,497.24. The notice of the upcoming sale was given in accordance with a plan adopted on 12/27/2023.
Recursion Pharmicals, Inc.高管兼董事克里斯托弗·吉布森定於2024年3月4日出售65,000股A類股票,總市值爲574,600美元。待售股票是通過各種方式收購的,包括創始人於2016年1月9日獲得的股票、2023年5月15日的限制性股票歸屬以及2023年7月6日和2023年12月7日行使股票期權。這些證券最初是作爲補償或通過現金支付獲得的。此次計劃出售是在過去三個月進行的一系列交易之後進行的,共出售了230,444股股票,總收益爲2,351,497.24美元。即將進行的出售通知是根據2023年12月27日通過的計劃發出的。
Recursion Pharmicals, Inc.高管兼董事克里斯托弗·吉布森定於2024年3月4日出售65,000股A類股票,總市值爲574,600美元。待售股票是通過各種方式收購的,包括創始人於2016年1月9日獲得的股票、2023年5月15日的限制性股票歸屬以及2023年7月6日和2023年12月7日行使股票期權。這些證券最初是作爲補償或通過現金支付獲得的。此次計劃出售是在過去三個月進行的一系列交易之後進行的,共出售了230,444股股票,總收益爲2,351,497.24美元。即將進行的出售通知是根據2023年12月27日通過的計劃發出的。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。